If you wanted to work with a surgeon, whom would you pick? Surgeons often lead double lives, and they can become inventors, award-winning technicians or be the first to conduct a particular surgery, such as Christiaan Neethling Barnard, a surgeon who performed the world’s first successful heart surgery. Also, some surgeons climb mountains and others report from foreign countries. This list of 11 surgery experts worth knowing includes surgeons who are interested in all the above and more.
This list is composed alphabetically by surname.
- Patrick J. Boland: Dr. Boland is a full-time, senior member of the Orthopaedic Service, Department of Surgery at Memorial Sloan-Kettering Cancer Center, where he specializes in the management of malignant and benign tumors of the bones, including those of the spine and pelvis, and in soft tissue sarcomas of the extremities. He has also authored and co-authored chapters and scientific papers on surgery for tumors of the extremities and the spine.
- Lorri Cobbins: Dr. Cobbins was among 1,467 doctors worldwide who became fellows of the American College of Surgeons (ACS) at the College’s 96th annual Clinical Congress in Washington, D.C. in 2010. Dr. Cobbins practices aesthetic plastic surgery at Clifton Springs Hospital & Clinic and has memberships in several other professional societies related to her interest in cosmetic surgery. While in medical school, Dr. Cobbins was a professional cheerleader for the Saint Louis Rams.
- Sanjay Gupta: Although most well known for his role as Emmy-award winning chief medical correspondent for CNN, Gupta also is a practicing neurosurgeon. In addition to his work for CNN, Gupta is a member of the staff and faculty at the Emory University School of Medicine. He is associate chief of neurosurgery at Grady Memorial Hospital and regularly performs surgery at Emory University and Grady hospitals. Gupta received his undergraduate degree from the University of Michigan and a doctorate of medicine from the University of Michigan Medical School.
- Stephen Pap: This plastic and hand surgeon recently joined the staff at Milton Hospital, a clinical affiliate of Beth Israel Deaconess Medical Center providing community-based health care in Massachusetts. Dr. Pap is also the proud founder and president of Hands Across the World, a non-profit organization that provides specialized surgery for congenital defects and other ailments in underserved areas of the world. Medical missions are hosted in Ecuador, where within one week as many as 90 patients receive surgical care. To date over 1,000 surgeries have been completed.
- Bohdan Pomahac: This name may be familiar as the surgeon who performed the first full face transplant in the U.S. He is the medical director for the Brigham and Women’s Hospital Burn Center in Boston and an assistant professor at Harvard Medical School. Dr. Pomahac performed the first face surgery on March 22, 2011, on a man who experienced an electric shock that removed his face. The Defense Department awarded a $3.4 million grant to the hospital in December 2009 to fund five face transplants.
- Charles B. Ross: Dr. Ross is the University of Louisville Chief of Vascular Surgery, and leads USA Vascular Group in Carotid Artery Stenting. Carotid artery stenting and carotid endarterectomy represent complementary options which are used to treat carotid arterial blockages in the neck to prevent stroke. In addition to the specialty of surgery, Dr. Ross has expertise in 10 areas. This includes vascular lower extremity ischemia, cerebrovascular surgery, renovascular disease plus others.
- David Satcher: Dr. David Satcher is Interim President of the Morehouse School of Medicine in Atlanta, Georgia. He was the 16th Surgeon General of the United States, sworn in on February 13, 1998, and served a 4-year term. Dr. Satcher is a former Robert Wood Johnson Clinical Scholar and Macy Faculty Fellow. He is the recipient of many honorary degrees and numerous distinguished honors. He is a Fellow of the American Academy of Family Physicians, American College of Preventive Medicine, and American College of Physicians.
- Margaret L. Schwarze: Dr. Schwarze was one of two applicants chosen for the Institute of Medicine of the National Academies fellowship in 2010. Not only is Schwarze a surgeon, but she also is a clinical bioethicist — or, a person who works on clinical issues in hospitals specifically studying how doctors interact with their patients and how they make decisions regarding life threatening illnesses. Dr. Schwarze is an assistant professor in the Division of Vascular Surgery at the University of Wisconsin’s Department of Surgery.
- Christopher Segler: Dr. Segler was awarded a patent in 2006 for his invention of the Tarsal Joint Space Distractor, an improved dual axis surgical retractor for use by orthopedic surgeons or podiatric surgeons for controlled distraction of tarsal joints (the small joints in the foot) or compression of osseus fragments (the foot bones). Dr. Segler is a rock climber, skier, marathon runner, and Ironman triathlete, and is part of the San Francisco Bay Area’s Ankle & Foot Center.
- Allan Stewart: Dr. Stewart, director of the Aortic Surgery Program at New York-Presbyterian Hospital/Columbia University Medical Center, provides expertise in all types of chronic and acute aortic problems, including valve-sparing aortic root replacement. A stentless biological aortic root-valve conduit that he developed, known as the “Stewart Procedure,” is gaining widespread use because of its advantages over other methods of replacing the aortic root.
- Sai Yendamuri: An assistant professor in the Department of Surgical Oncology and Thoracic Oncology at Roswell Park Cancer Institute (RPCI), Dr. Yendamuri has been awarded a $555,103 grant from the U.S. Army to develop a way to help predict which lung-cancer patients are more likely to have their cancer recur after surgery. Dr. Yendamuri plans to explore the potential of using microRNA profiling as a biomarker for non-small-cell lung cancer. Separating the tumor’s epithelial and stromal components using laser-capture dissection, rather than using whole-tumor tissue, will be key to the marker’s novelty.